GnRH agonists in the treatment of symptomatic endometriosis: a review

The development of highly potent gonadotropin-releasing hormone agonists (GnRHa) allowed for a significant addition to options for the medical management of symptomatic endometriosis. Pituitary GnRH receptor down-regulation leads to a hypogonadotropic and secondary hypoestrogenic state resulting in...

Descripción completa

Detalles Bibliográficos
Autor principal: Surrey, Eric S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Special Issue
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10201290/
https://www.ncbi.nlm.nih.gov/pubmed/37223763
http://dx.doi.org/10.1016/j.xfre.2022.11.009

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10201290/
https://www.ncbi.nlm.nih.gov/pubmed/37223763
http://dx.doi.org/10.1016/j.xfre.2022.11.009

Ejemplares similares